Re: Maarten de Rooij, Simone Crienen, J. Alfred Witjes, Jelle O. Barentsz, Maroeska M. Rovers, Janneke P.C. Grutters. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.12.012
- PMID: 24830624
- DOI: 10.1016/j.eururo.2014.04.011
Re: Maarten de Rooij, Simone Crienen, J. Alfred Witjes, Jelle O. Barentsz, Maroeska M. Rovers, Janneke P.C. Grutters. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.12.012
Comment in
-
Reply to Sarah Willis, Alec Miners, and Jan van der Meulen's letter to the editor re: Maarten de Rooij, Simone Crienen, J. Alfred Witjes, Jelle O. Barentsz, Maroeska M. Rovers, Janneke P.C. Grutters. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.12.012.Eur Urol. 2014 Aug;66(2):e30. doi: 10.1016/j.eururo.2014.04.012. Epub 2014 May 2. Eur Urol. 2014. PMID: 24837186 No abstract available.
Comment on
-
Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.Eur Urol. 2014 Sep;66(3):430-6. doi: 10.1016/j.eururo.2013.12.012. Epub 2013 Dec 21. Eur Urol. 2014. PMID: 24377803
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical